Exchange Traded Concepts’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-204,282
Closed -$3.14M 1584
2025
Q4
$3.14M Buy
204,282
+3,306
+2% +$36.4K 0.02% 495
2025
Q3
$2M Buy
200,976
+67,375
+50% +$701K 0.02% 570
2025
Q2
$1.33M Buy
133,601
+5,523
+4% +$58.2K 0.02% 583
2025
Q1
$1.66M Sell
128,078
-34,648
-21% -$458K 0.03% 427
2024
Q4
$2.08M Buy
162,726
+6,712
+4% +$81.2K 0.04% 367
2024
Q3
$1.74M Buy
156,014
+104,382
+202% +$1.15M 0.04% 371
2024
Q2
$580K Buy
51,632
+2,484
+5% +$28.9K 0.01% 664
2024
Q1
$610K Sell
49,148
-8,445
-15% -$110K 0.02% 628
2023
Q4
$805K Buy
57,593
+828
+1% +$11.5K 0.02% 445
2023
Q3
$838K Sell
56,765
-13,609
-19% -$191K 0.02% 422
2023
Q2
$909K Sell
70,374
-30
-0% -$342 0.02% 410
2023
Q1
$691K Buy
+70,404
New +$752K 0.02% 405

Other funds holding DVAX

Exchange Traded Concepts's DVAX Position: Q1 2026 in Review

Exchange Traded Concepts sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 204,282 shares — an estimated $3.14M sold.

Exchange Traded Concepts first reported a position in DVAX in Q1 2023 and held it in 12 quarters. The position peaked at $3.14M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Exchange Traded Concepts reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Exchange Traded Concepts sold 204,282 Dynavax Technologies shares in Q1 2026, an estimated $3.14M.
  • Exchange Traded Concepts first reported a position in Dynavax Technologies in Q1 2023 and held it in 12 quarters.
  • Exchange Traded Concepts's Dynavax Technologies position peaked at $3.14M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.